Glenmark Life Sciences readies $203m Indian IPO

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Glenmark Life Sciences readies $203m Indian IPO

Jonathan Breen
July 26, 2021 08:15 am
biopharma_stocks_adobe_575x375.jpg
Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Pharmaceutical ingredients manufacturer Glenmark Life Sciences is set to launch a Rp15.1bn ($202.6m) IPO on Tuesday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechEquityBank of AmericaIndiaAsiaSouth AsiaAsia PacificEmerging MarketsSRIState Bank of India SBIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article